Yan et al. (35) investigated the therapeutic efficacy of concurrent gonadotropin-releasing hormone (GnRH) agonist administration and DNG supplementation following focused ultrasound ablation surgery in patients with adenomyosis. Here, GNRH1 is linked to adenomyosis.